Alpha 1-antitrypsin deficiency in Europe: geographical distribution of Pi types S and Z
- PMID: 9692092
- DOI: 10.1016/s0954-6111(98)90278-5
Alpha 1-antitrypsin deficiency in Europe: geographical distribution of Pi types S and Z
Abstract
alpha 1-Antitrypsin (AT) is the principal serum inhibitor of proteolytic enzymes such as neutrophil elastase. AT can exist as over 90 different genetically determined variants known as the Pi system; the three most important variants are type M (90% of population) and types S and Z, two of the commoner abnormal variants. Homozygotes of type Z have a severe reduction in the serum AT concentration and may develop pulmonary emphysema or hepatic cirrhosis. Heterozygotes of type SZ have a less severe reduction in serum AT concentration and the association with clinical disease is less clear. The S and Z variants are found mainly among those of European stock. The gene frequency for Pi type Z is highest on the north-western seaboard of the continent and the mutation seems likely to have arisen in southern Scandinavia. The distribution of type S is quite different; the gene frequency is highest in the Iberian peninsula and the mutation is likely to have arisen in that region. A population survey for determining the number of type Z homozygotes in a given community is important for planning purposes now that AT replacement therapy is potentially available.
Comment in
-
Alpha1-anti-trypsin deficiency: epidemiology and incidence.Respir Med. 2002 Mar;96(3):205. doi: 10.1053/rmed.2001.1246. Respir Med. 2002. PMID: 11905555 No abstract available.
Similar articles
-
The epidemiology of alpha 1-antitrypsin deficiency.Lung. 1990;168 Suppl:535-42. doi: 10.1007/BF02718176. Lung. 1990. PMID: 2117162 Review.
-
Estimated numbers and prevalence of PI*S and PI*Z alleles of alpha1-antitrypsin deficiency in European countries.Eur Respir J. 2006 Jan;27(1):77-84. doi: 10.1183/09031936.06.00062305. Eur Respir J. 2006. PMID: 16387939
-
Estimated numbers and prevalence of PI*S and PI*Z deficiency alleles of alpha1-antitrypsin deficiency in Asia.Eur Respir J. 2006 Dec;28(6):1091-9. doi: 10.1183/09031936.00029806. Epub 2006 Sep 27. Eur Respir J. 2006. PMID: 17005586
-
Alpha-1 antitrypsin Pi*SZ genotype: estimated prevalence and number of SZ subjects worldwide.Int J Chron Obstruct Pulmon Dis. 2017 Jun 8;12:1683-1694. doi: 10.2147/COPD.S137852. eCollection 2017. Int J Chron Obstruct Pulmon Dis. 2017. PMID: 28652721 Free PMC article.
-
Natural history of alpha-1-protease inhibitor deficiency.Am J Med. 1988 Jun 24;84(6A):3-12. doi: 10.1016/0002-9343(88)90153-2. Am J Med. 1988. PMID: 3289386 Review.
Cited by
-
Known Mutations at the Cause of Alpha-1 Antitrypsin Deficiency an Updated Overview of SERPINA1 Variation Spectrum.Appl Clin Genet. 2021 Mar 22;14:173-194. doi: 10.2147/TACG.S257511. eCollection 2021. Appl Clin Genet. 2021. PMID: 33790624 Free PMC article. Review.
-
Liver Disease and Prevalence of Liver Transplantation in Adults With ZZ Alpha-1 Antitrypsin Deficiency-A Meta-Analysis.Liver Int Commun. 2025 Jun;6(2):e70013. doi: 10.1002/lci2.70013. Epub 2025 Apr 11. Liver Int Commun. 2025. PMID: 40248356 Free PMC article.
-
Diagnosing alpha-1 antitrypsin deficiency: does it prevent or improve the course of COPD?J Bras Pneumol. 2016 Sep-Oct;42(5):307-308. doi: 10.1590/S1806-37562016000400002. J Bras Pneumol. 2016. PMID: 27812626 Free PMC article. No abstract available.
-
Comparing Patients with ZZ Versus SZ Alpha-1 Antitrypsin Deficiency: Findings from AlphaNet's Disease Management Program.Chronic Obstr Pulm Dis. 2018 Nov 30;6(1):29-39. doi: 10.15326/jcopdf.6.1.2018.0134. Chronic Obstr Pulm Dis. 2018. PMID: 30775422 Free PMC article.
-
Alpha-1 antitrypsin deficiency: a conformational disease associated with lung and liver manifestations.J Inherit Metab Dis. 2008 Feb;31(1):21-34. doi: 10.1007/s10545-007-0748-y. Epub 2008 Jan 16. J Inherit Metab Dis. 2008. PMID: 18193338 Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous